当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
TESTOSTERONE 4mg
HUMAN COMPOUNDED DRUG
26436-5403
Hybrid Pharma
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg/1 g
26436-5403-1
Povidone Iodine
HUMAN COMPOUNDED DRUG
5446-1680
Edge Pharma LLC
2021/2/1 0:00:00
IODINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL
5446-1680-01
Phenylephrine HCl 20mg
HUMAN COMPOUNDED DRUG
5446-1667
Edge Pharma LLC
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/250 mL
5446-1667-10
Phenylephrine HCl 1mg/10mL
HUMAN COMPOUNDED DRUG
5446-1544
Edge Pharma LLC
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/10 mL
5446-1544-10
Lidocaine, Tetracaine 23/7
HUMAN COMPOUNDED DRUG
5446-1647
Edge Pharma LLC
2021/2/1 0:00:00
LIDOCAINE; TETRACAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
23 mg/1 g; 7 mg/1 g
5446-1647-01
Phenylephrine HCl 1mg/5mL
HUMAN COMPOUNDED DRUG
5446-1545
Edge Pharma LLC
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/10 mL
5446-1545-05
CIPROFLOXACIN / SULFACETAMIDE SODIUM / AMPHOTERICIN B / HYDROCORTISONE 30MG / 50MG / 5MG / 25MG
HUMAN COMPOUNDED DRUG
5446-1634
Edge Pharma LLC
2021/2/1 0:00:00
SULFACETAMIDE SODIUM; AMPHOTERICIN B; CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg; 5 mg; 30 mg; 25 mg
5446-1634-05
Rocuronium Bromide
HUMAN COMPOUNDED DRUG
71266-9005
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
ROCURONIUM BROMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71266-9005-5
Phenylephrine HCl
HUMAN COMPOUNDED DRUG
71266-9010
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 mg/1 mL
71266-9010-1
Phenylephrine HCl
HUMAN COMPOUNDED DRUG
71266-9010
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 mg/1 mL
71266-9010-2
Succinylcholine Chloride
HUMAN COMPOUNDED DRUG
71266-9684
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
71266-9684-5
Neostigmine Methylsulfate
HUMAN COMPOUNDED DRUG
71266-2003
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
NEOSTIGMINE METHYLSULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71266-2003-1
Neostigmine Methylsulfate
HUMAN COMPOUNDED DRUG
71266-2003
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2021/2/1 0:00:00
NEOSTIGMINE METHYLSULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71266-2003-2
Hydromorphone
HUMAN COMPOUNDED DRUG
70214-3011
PROVIDENCE INFUSION HOSPITAL SERVICES
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 mg/30 mL
70214-3011-1
fentaNYL
HUMAN COMPOUNDED DRUG
70214-3020
PROVIDENCE INFUSION HOSPITAL SERVICES
2021/2/1 0:00:00
FENTANYL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1500 ug/30 mL
70214-3020-1
fentaNYL
HUMAN COMPOUNDED DRUG
70214-4011
PROVIDENCE INFUSION HOSPITAL SERVICES
2021/2/1 0:00:00
BUPIVACAINE, (R)-; FENTANYL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
312.5 mg/250 mL; 500 ug/250 mL
70214-4011-1
Trimix 120/30/3
HUMAN COMPOUNDED DRUG
26436-5508
Hybrid Pharma
2021/2/1 0:00:00
PAPAVERINE HYDROCHLORIDE; ALPROSTADIL; PHENTOLAMINE MESYLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 mg/1 mL; 120 ug/1 mL; 3 mg/1 mL
26436-5508-1
Trimix 10/30/2
HUMAN COMPOUNDED DRUG
26436-5352
Hybrid Pharma
2021/2/1 0:00:00
ALPROSTADIL; PAPAVERINE HYDROBROMIDE; PHENTOLAMINE MESYLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL; 30 mg/1 mL; 2 mg/1 mL
26436-5352-5
Trimix 60/30/4
HUMAN COMPOUNDED DRUG
26436-5155
Hybrid Pharma
2021/2/1 0:00:00
PAPAVERINE HYDROCHLORIDE; ALPROSTADIL; PHENTOLAMINE MESYLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 mg/1 mL; 60 ug/1 mL; 4 mg/1 mL
26436-5155-5
LET Topical Gel
HUMAN COMPOUNDED DRUG
26436-5311
Hybrid Pharma
2021/2/1 0:00:00
TETRACAINE; LIDOCAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL; 40 mg/1 mL
26436-5311-1
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3